tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CGTX Stock Latest News

Cognition Therapeutics presents results at AD/PD 2025 on CT1812
The FlyCognition Therapeutics presents results at AD/PD 2025 on CT1812
18d ago
CGTX
Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications
PremiumRatings
Buy Recommendation for Cognition Therapeutics: Promising Phase 2 Results and Strategic Focus on Alzheimer’s and Dementia Indications
25d ago
CGTX
Cognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe Fly
Cognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
26d ago
CGTX
Cognition Therapeutics Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Cognition Therapeutics Earnings Call: Progress Amid Challenges
28d ago
CGTX
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
PremiumThe Fly
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
29d ago
CGTX
Cognition Therapeutics Advances Alzheimer’s and DLB Trials
PremiumCompany AnnouncementsCognition Therapeutics Advances Alzheimer’s and DLB Trials
29d ago
CGTX
Cognition Therapeutics reports FY24 EPS (86c), consensus (74c)
Premium
The Fly
Cognition Therapeutics reports FY24 EPS (86c), consensus (74c)
30d ago
CGTX
Is CGTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is CGTX a Buy, Before Earnings?
1M ago
CGTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
IPA
PBM
Cognition Therapeutics publishes research on zervimesine in dry AMD
PremiumThe Fly
Cognition Therapeutics publishes research on zervimesine in dry AMD
2M ago
CGTX
Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study
PremiumThe Fly
Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study
2M ago
CGTX
Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit
PremiumThe Fly
Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit
2M ago
CGTX
Cognition announces publication of zervimesine manufacturing process
PremiumThe FlyCognition announces publication of zervimesine manufacturing process
2M ago
CGTX
Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley
Premium
The Fly
Cognition Therapeutics price target raised to $2 from $1.50 at B. Riley
2M ago
CGTX
Cognition announces Phase 2 ‘SHIMMER’ study to be presented at ILBDC
Premium
The Fly
Cognition announces Phase 2 ‘SHIMMER’ study to be presented at ILBDC
3M ago
CGTX
Cognition Therapeutics Shows Promising Phase 2 Study Results
PremiumCompany Announcements
Cognition Therapeutics Shows Promising Phase 2 Study Results
3M ago
8K
CGTX
B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies data
PremiumThe Fly
B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies data
4M ago
CGTX
Cognition Therapeutics upgraded to Buy from Neutral at B. Riley
PremiumThe Fly
Cognition Therapeutics upgraded to Buy from Neutral at B. Riley
4M ago
CGTX
Cognition Therapeutics price target raised to $6 from $5 at H.C. Wainwright
PremiumThe Fly
Cognition Therapeutics price target raised to $6 from $5 at H.C. Wainwright
4M ago
CGTX
Cognition Therapeutics announces results in Phase 2 study of CT1812
PremiumThe FlyCognition Therapeutics announces results in Phase 2 study of CT1812
4M ago
CGTX
Cognition announces all participants completed final visit in SHIMMER study
Premium
The Fly
Cognition announces all participants completed final visit in SHIMMER study
5M ago
CGTX
Cognition Therapeutics provided an update on Phase 2 ‘SHINE’ study analysis
Premium
The Fly
Cognition Therapeutics provided an update on Phase 2 ‘SHINE’ study analysis
5M ago
CGTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >